Filing Details

Accession Number:
0001352414-14-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-20 17:38:53
Reporting Period:
2014-02-20
Filing Date:
2014-02-20
Accepted Time:
2014-02-20 17:38:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352414 S James Evans 320 Wakara Way
Salt Lake City UT 84108
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-20 30,000 $7.27 77,609 No 4 M Direct
Common Stock Disposition 2014-02-20 30,000 $36.01 47,609 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2014-02-20 30,000 $0.00 30,000 $7.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-09-14 No 4 M Direct
Footnotes
  1. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.